MACK
Legal & General Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-980
| Closed | -$14.5K | – | 3583 |
|
|
2024
Q1 | $14.5K | Sell |
980
-306
| -24% | -$4.52K | ﹤0.01% | 3104 |
|
|
2023
Q4 | $17.2K | Hold |
1,286
| – | – | ﹤0.01% | 3088 |
|
|
2023
Q3 | $15.9K | Hold |
1,286
| – | – | ﹤0.01% | 3120 |
|
|
2023
Q2 | $15.8K | Buy |
+1,286
| New | +$15.8K | ﹤0.01% | 3211 |
|
|
2018
Q2 | – | Sell |
-2,700
| Closed | -$22K | – | 3473 |
|
|
2018
Q1 | $22K | Sell |
2,700
-1,034
| -28% | -$8.43K | ﹤0.01% | 3095 |
|
|
2017
Q4 | $39K | Hold |
3,734
| – | – | ﹤0.01% | 2955 |
|
|
2017
Q3 | $54K | Sell |
3,734
-31,543
| -89% | -$456K | ﹤0.01% | 2895 |
|
|
2017
Q2 | $43K | Hold |
35,277
| – | – | ﹤0.01% | 2951 |
|
|
2017
Q1 | $108K | Sell |
35,277
-1,514
| -4% | -$4.64K | ﹤0.01% | 2500 |
|
|
2016
Q4 | $151K | Buy |
36,791
+11,521
| +46% | +$47.3K | ﹤0.01% | 2341 |
|
|
2016
Q3 | $159K | Sell |
25,270
-1,496
| -6% | -$9.41K | ﹤0.01% | 2091 |
|
|
2016
Q2 | $144K | Hold |
26,766
| – | – | ﹤0.01% | 1905 |
|
|
2016
Q1 | $226K | Buy |
26,766
+7,732
| +41% | +$65.3K | ﹤0.01% | 1694 |
|
|
2015
Q4 | $151K | Hold |
19,034
| – | – | ﹤0.01% | 1871 |
|
|
2015
Q3 | $159K | Buy |
19,034
+3,722
| +24% | +$31.1K | ﹤0.01% | 1810 |
|
|
2015
Q2 | $185K | Hold |
15,312
| – | – | ﹤0.01% | 1785 |
|
|
2015
Q1 | $182K | Hold |
15,312
| – | – | ﹤0.01% | 1721 |
|
|
2014
Q4 | $173K | Sell |
15,312
-537
| -3% | -$6.07K | ﹤0.01% | 1650 |
|
|
2014
Q3 | $139K | Buy |
+15,849
| New | +$139K | ﹤0.01% | 1697 |
|